← Open Payments lookup

MICHAEL HUANG: Open Payments

NPI 1548716004 · CONCORD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$302 in 14 payments from 8 companies in 2025. Trend: 2023 $228 · 2024 $560 · 2025 $302

Food & beverage: $302
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc3$88
Gilead Sciences, Inc.3$73
Otsuka America Pharmaceutical, Inc.3$61
E.R. Squibb & Sons, L.L.C.1$19
ABBVIE INC.1$17
Sage Therapeutics, LLC1$15
Supernus Pharmaceuticals, Inc.1$15
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$14

Products named: SPRAVATO, ABILIFY ASIMTUFII, REXULTI, COBENFY, VRAYLAR, ZURZUVAE, Qelbree, CAPLYTA.

Industry payments across MA — which companies pay providers there.